Foreword

Experimental Diabesity Research

Volumn 5, Issue 1, 2004, Pages 3-5

  Vinik, Aaron ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); C PEPTIDE; PROINSULIN; INSULIN;

CALCIUM SIGNALING; DIABETIC NEUROPATHY; EDITORIAL; ENZYME ACTIVATION; HORMONAL REGULATION; HORMONE ACTION; HORMONE STRUCTURE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SYNTHESIS; INTRACELLULAR TRANSPORT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; ANIMAL; BLOOD VESSEL; CHEMISTRY; HOSPITALIZATION; METABOLISM; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; BLOOD VESSELS; C-PEPTIDE; DIABETIC NEUROPATHIES; HUMANS; INSULIN; MICROCIRCULATION; NA(+)-K(+)-EXCHANGING ATPASE; SEVERITY OF ILLNESS INDEX;

EID: 4844226735     PISSN: 15438600     EISSN: None     Source Type: Journal    
DOI: 10.1080/15438600490447816     Document Type: Editorial

References (20)

1. Cameron, N. E., Eaton, S. E. M., Cotter, M. A., and Tesfaye, S. (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia, 44, 1973-1988.
2. Ekberg, K., Brismar, T., Johansson, B. L., Jonsson, B., Lindstrom, P., and Wahren, J. (2003) Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes. Diabetes, 52, 536-541.
3. Grunberger, G., Qiang, X., Li, Z., Mathews, S. T., Sbrissa, D., Shisheva, A., and Sima, A. A. F. (2001) Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia, 44, 1247-1257.
4. Henriksson, M., Pramanik, A., Shafqat, J., Zhong, Z., Tally, M., Ekberg, K., Wahren, I., Rigler, R., Johansson, J., and Jörnvall, H. (2001) Specific binding of proinsulin C-peptide to intact and to detergent-solubilized human skin fibroblasts. Biochem. Biophys. Res. Commun., 280, 423-427.
5. Ido, Y., Vindigni, A., Chang, K., Stramm, L., Chance, R., Heath, W. E., DiMarchi, R. D., Di Cera, E., and Williamson, J. R. (1997) Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science, 277, 563-566.
6. Kitamura, T., Kimura, K., Jung, B. D., Makondo, K., Okamoto, S., Canas, X., Sakane, N., Yoshida, T., and Saito, M. (2001) Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein. Biochem. J., 355, 123-129.
7. Li, Z.-G., and Sima, A. A. F. (2004) C-peptide and central nervous system complications in diabetes. Exp. Diab. Res., 5, 79-90.
8. Rigler, R., Pramanik, A., Jonasson, P., Kratz, G., Jansson, O. T., Nygren, P., Stahl, S., Ekberg, K., Johansson, B., Uhlen, S., Uhlen, M., Jörnvall, H., and Wahren, J. (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proc. Natl. Acad. Sci. U.S.A., 96, 13318-13323.
9. Sima, A. A. F., Zhang, W., Sugimoto, K., Henry, D., Li, Z., Wahren, J., and Grunberger, G. (2001) C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat. Diabetologia, 44, 889-897.
10. Sima, A. A. F. (2003) C-peptide and diabetic neuropathy. Expert Opin. Investig. Drugs, 12, 1471-1488.
11. Sima, A. A. F., Li, Z.-G., and Zhang, W. (2003) The insulin-like growth factor system and neurological complications in diabetes. Exp. Diabesity. Res., 4, 235-256.
12. Sima, A. A. F., and Shafrir, E. (2003) Editorial. Exp. Diabesity. Res., 4, i.
13. Sima A. A. F., Zhang, W., and Grunberger, G. (2004) Type 1 diabetic neuropathy and C-peptide. Exp. Diab. Res., 5, 65-77.
14. Steiner, D. F. (1967) Evidence for a precursor in the biosynthesis of insulin. Trans. N. Y. Acad. Sci., 30, 60-68.
15. Vinik, A., Erbas, T., Park, T., Stansberry, K., Scanelli, J., and Pittenger, G. (2001) Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care, 24(8), 1468-1475.
16. Vinik, A., Pittenger, G., Barlow, P., and Mehrabyan, A. (2004) Diabetic neuropathies an overview of clinical aspects, pathogenesis, and treatment. LeRoith, D., Taylor, S., and Olefsky, J. Diabeties Mellitus (3rd Edition), 1331-1363. Philadelphia: Lippincott Williams and Wilkins.
17. Wahren, J., Johansson, B. I., and Wallberg-Henriksson, H. (1994) Does C-peptide have a physiological role? Diabetologia, 37(Suppl 2), S99-107.
18. Wahren, J., Ekberg, K., Johansson, J., Henriksson, M., Pramanik, A., Johansson, B. I., Rigler, R., and Jörnvall, H. (2000) Role of C-peptide in human physiology. Am. J. Physiol. Endocrinol. Metab., 278, E759-E768.
19. Wahren, J., and Jörnvall, H. C. (2003) C-peptide makes a comeback. Diabetes Metab. Res. Rev., 19, 345-347.
20. Zierath, J. R., Handberg, A., Tally, M., and Wallberg-Henriksson, H. (1996) C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia, 39, 306-313.